Iron Dysregulation in Cardiovascular Diseases

被引:1
|
作者
Wang, Hui [1 ]
Huang, Zhongmin [1 ]
Du, Chenyan [1 ]
Dong, Mingqing [1 ]
Fragasso, Gabriele [1 ]
机构
[1] Chengdu Fifth Peoples Hosp, Geriatr Dis Inst Chengdu, Ctr Med Res & Translat, Chengdu 611137, Sichuan, Peoples R China
关键词
iron metabolism; homeostasis; cardiovascular disease; dysregulation; CHRONIC HEART-FAILURE; FERRIC CARBOXYMALTOSE; DEFICIENCY ANEMIA; HEREDITARY HEMOCHROMATOSIS; ENDOTHELIAL DYSFUNCTION; TRANSFERRIN RECEPTOR; EXERCISE CAPACITY; OXIDATIVE STRESS; OVERLOAD; HEPCIDIN;
D O I
10.31083/j.rcm2501016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Iron metabolism plays a crucial role in various physiological functions of the human body, as it is essential for the growth and development of almost all organisms. Dysregulated iron metabolism-manifested either as iron deficiency or overload-is a significant risk factor for the development of cardiovascular disease (CVD). Moreover, emerging evidence suggests that ferroptosis, a form of iron-dependent programed cell death, may also contribute to CVD development. Understanding the regulatory mechanisms of iron metabolism and ferroptosis in CVD is important for improving disease management. By integrating different perspectives and expertise in the field of CVD-related iron metabolism, this overview provides insights into iron metabolism and CVD, along with approaches for diagnosing, treating, and preventing CVD associated with iron dysregulation.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Dysregulation of TCTP in Biological Processes and Diseases
    Bommer, Ulrich-Axel
    Telerman, Adam
    CELLS, 2020, 9 (07)
  • [42] Cell cycle dysregulation and neurodegenerative diseases
    Smith, Mark A.
    Arendt, Thomas
    Vincent, Inez
    Zhu, Xiongwei
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (04): : 391 - 391
  • [43] Dysregulation of histone deacetylases in ocular diseases
    Jae Hyun Jun
    Jun-Sik Kim
    Leon F. Palomera
    Dong-Gyu Jo
    Archives of Pharmacal Research, 2024, 47 (1) : 20 - 39
  • [44] Immune Dysregulation in Human Telomere Diseases
    Gomes, Willian R.
    Carvalho, Vinicius S.
    Santana, Barbara A.
    Martinez, Edson Z.
    Ramalho, Leandra Z.
    Condino-Neto, Antonio
    Calado, Rodrigo T.
    BLOOD, 2022, 140 : 8668 - 8670
  • [45] Diseases of complement dysregulation-an overview
    Wong, Edwin K. S.
    Kavanagh, David
    SEMINARS IN IMMUNOPATHOLOGY, 2018, 40 (01) : 49 - 64
  • [46] Autophagy and microRNA dysregulation in liver diseases
    Kim, Kyu Min
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (09) : 1097 - 1116
  • [47] Hyaluronan in immune dysregulation and autoimmune diseases
    Nagy, Nadine
    Kuipers, Hedwich F.
    Marshall, Payton L.
    Wang, Esther
    Kaber, Gernot
    Bollyky, Paul L.
    MATRIX BIOLOGY, 2019, 78-79 : 292 - 313
  • [48] Targeted Treatment of Diseases of Immune Dysregulation
    Mohan, Smriti
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2023, 49 (04) : 913 - 929
  • [49] RNA Dysregulation in Diseases of Motor Neurons
    Ibrahim, Fadia
    Nakaya, Tadashi
    Mourelatos, Zissimos
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7, 2012, 7 : 323 - 352
  • [50] Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
    Johnson, William M.
    Wilson-Delfosse, Amy L.
    Mieyal, John. J.
    NUTRIENTS, 2012, 4 (10) : 1399 - 1440